Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health's Crofelemer
Portfolio Pulse from
Ladenburg Thalmann will host a Scientific Showcase on December 18, 2024, focusing on Jaguar Health's Crofelemer, which is undergoing five clinical trials for rare diseases. Results from these trials are expected in Q2 2025.
December 13, 2024 | 3:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jaguar Health's Crofelemer is undergoing five clinical trials for rare diseases, with results expected in Q2 2025. A Scientific Showcase will be held on December 18, 2024.
The announcement of a Scientific Showcase and ongoing clinical trials for Crofelemer could generate positive sentiment and investor interest in Jaguar Health. The potential for positive trial results in Q2 2025 adds to the optimism.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100